UniProt ID | Protein Name | Gene Symbol | No. of Glycosylation Sites | No. of GlyTouCan IDs | Disease Ontology |
---|---|---|---|---|---|
A0A8C0HYA5 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A8B8Y397 | Potassium channel subfamily K member |
|
1 | 0 |
|
A0A8B8X161 | Voltage-dependent P/Q-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A8C0HZ21 | Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase |
|
1 | 0 |
|
A0A8B8YN09 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A8B8YM93 | Phosphoinositide phospholipase C |
|
2 | 0 |
|
A0A8B8X1A1 | Voltage-dependent P/Q-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A8C0E978 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A8B8VHL0 | Fibroblast growth factor receptor |
|
8 | 0 |
|
A0A8C0HXJ3 | Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase |
|
1 | 0 |
|
A0A8C0ECL3 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A8B8X195 | Voltage-dependent P/Q-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A8B8YUX0 | Rhodopsin |
|
2 | 0 |
|
A0A8B8XAJ2 | Peptidyl-glycine alpha-amidating monooxygenase isoform X7 |
|
1 | 0 |
|
A0A8B8YPZ5 | Hyaluronidase |
|
1 | 0 |
|
A0A8C0E079 | N-acetylgalactosamine-6-sulfatase |
|
2 | 0 |
|
A0A8C0CZ39 | Paraoxonase |
|
2 | 0 |
|
A0A8C0I003 | Voltage-dependent P/Q-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A8B8YM99 | Phosphoinositide phospholipase C |
|
2 | 0 |
|
A0A8B8WB82 | Fibroblast growth factor receptor |
|
8 | 0 |
|
A0A8B8YX03 | Potassium channel subfamily K member 16 |
|
1 | 0 |
|
A0A8B8Y8E2 | L-selectin |
|
3 | 0 |
|
A0A8B8VKS4 | GDNF family receptor alpha-1 |
|
2 | 0 |
|
A0A8C0CNF4 | Hyaluronidase |
|
1 | 0 |
|
R4L1T0 | Rhodopsin (Fragment) |
|
2 | 0 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024